Month: November 2024

Zahrawi Group is thrilled to announce its active participation in the 13th Emirates International Urology Congress, held at the heart of Dubai. This congress serves as a vital platform for urology professionals worldwide, where cutting-edge technologies are shared, knowledge is exchanged, and future advancements in patient care are discussed.

At Zahrawi Group, we believe that the future of healthcare lies in innovation and collaboration. Our participation in this event aligns perfectly with our vision of driving meaningful change in the healthcare landscape by bringing innovative solutions that help clinicians improve patient outcomes.

One of the highlights of our presence this year is the LaserClast Thulium Power machine, a state-of-the-art solution from our esteemed partner, EMS. Known for its precision and efficiency in the management of kidney stones, this technology is shaping the future of urological care. The response from the medical community has been overwhelmingly positive, as professionals see how this machine can redefine patient treatments.

Alongside the LaserClast, we also introduced a wide array of urology solutions from our trusted partners, including Laborie, Optilume, EDAP, Rocamed, and Anqing Innovex. These solutions, spanning diagnostics, therapy, and procedural innovations, are carefully selected to meet the growing and diverse needs of urologists in the region.

As the healthcare landscape rapidly evolves, Zahrawi Group is proud to be at the forefront, not just as a distributor, but as a partner in progress, helping medical professionals raise the standard of care with innovative solutions tailored to the region’s needs.

Zahrawi Group, in partnership with Cepheid, proudly participated in the 8th Annual UAE Infectious Disease (ID) Week Conference at Sofitel Abu Dhabi corniche. This event in the Middle East stands as a reference conference for infectious diseases, vaccination programs, and strategies to combat microbial resistance, bringing together leading experts and clinicians from various fields such as public health, epidemiology, immunology, and microbiology.

Zahrawi Group’s Lab team had the opportunity to showcase the GeneXpert Xpress CLIA-waived system for Point-of-Care Testing (POCT) from our partner Cepheid during the event, emphasizing its role in delivering rapid, reliable diagnostics directly to patients.

Additionally, the Director of Clinical Solutions, Dr. Ahmed Madian from Cepheid, delivered an insightful speech titled “Molecular Diagnostics with a Side of Antimicrobial Stewardship,” highlighting the critical role of advanced diagnostics in tackling antimicrobial resistance. Zahrawi’s efforts were further recognized when the team was awarded for their participation by Dr. Emmanuel (May his soul rest in peace), Chair of the Tropical and Infectious Disease Division at Sheikh Shakhbout Medical City, Abu Dhabi, UAE.

Our collaboration with Cepheid during this conference aligns with our commitment to improving healthcare outcomes by ensuring access to the latest and most advanced molecular diagnostics solutions.